The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells
- 6 August 2003
- journal article
- Published by Springer Nature in Oncogene
- Vol. 22 (32), 4953-4963
- https://doi.org/10.1038/sj.onc.1206656
Abstract
We demonstrate that PS-341, a small molecule inhibitor of the proteasome, markedly sensitizes resistant prostate, colon, and bladder cancer cells to TNF-like apoptosis-inducing ligand (TRAIL)-induced apoptosis irrespective of Bcl-xL overexpression. PS-341 treatment by itself does not affect the levels of Bax, Bak, caspases 3 and 8, c-Flip or FADD, but elevates levels of TRAIL receptors DR4 and DR5. This increase in receptor protein levels is associated with the ubiquitination of the DR5 protein. When PS-341 is combined with TRAIL, the levels of activated caspase 8 and cleaved Bid are substantially increased. In Bax-negative TRAIL-resistant HC-4 colon cancer cells, the combination of PS-341 and TRAIL overcomes the block to activation of the mitochondrial pathway and causes SMAC and cytochrome c release followed by apoptosis. Similarly, murine embryonic fibroblasts lacking Bax undergo apoptosis when exposed to the combination of PS-341 and TRAIL; however, fibroblasts lacking Bak are significantly resistant. Taken together, these findings indicate that PS-341 enhances TRAIL-induced apoptosis by increasing the cleavage of caspase 8, causing Bak-dependent release of mitochondrial proapoptotic proteins.Keywords
This publication has 45 references indexed in Scilit:
- Erythroid Differentiation Sensitizes K562 Leukemia Cells to TRAIL-Induced Apoptosis by Downregulation of c-FLIPMolecular and Cellular Biology, 2003
- Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cellsOncogene, 2002
- Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemiaLeukemia, 2002
- A Role for Mitochondrial Bak in Apoptotic Response to Anticancer DrugsJournal of Biological Chemistry, 2001
- TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2Oncogene, 2001
- Cisplatin Induces the Proapoptotic Conformation of Bak in a ΔMEKK1-Dependent MannerMolecular and Cellular Biology, 2001
- Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosisOncogene, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- Inhibition of Death Receptor-mediated Gene Induction by a Cycloheximide-sensitive Factor Occurs at the Level of or Upstream of Fas-associated Death Domain Protein (FADD)Published by Elsevier ,2000
- APO2 ligand: a novel lethal weapon against malignant glioma?FEBS Letters, 1998